North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis- By Treatment, Allergy type, Distribution Channel and Geography

▴ North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis- By Treatment, Allergy type, Distribution Channel and Geography
North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis- By Treatment, Allergy type, Distribution Channel and Geography

This can be attributed to the increasing developments in the healthcare sector. The rising initiatives by various research institutes and organizations for improving medical facilities and services are further leading to the market growth.

Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. According to the American Academy of Allergy, Asthma, and Immunology (AAAAI), 7.8% of people aged 18 years and above in the US have allergic rhinitis. Further, 30% of the global population is affected by hay fever annually. Positive results of various immunotherapies that are in clinical trials encourage the development activities of allergy immunotherapy-based drugs. Thus, growing prevalence of different allergies and increasing drug development activities boost the North America allergy immunotherapies market growth. The market players are also adopting business expansion, collaboration, and new product development strategies to increase their market footprint.
The COVID-19 pandemic has harmed the North America allergy immunotherapies market size, with small and medium-scale companies struggling to sustain their businesses in the near future. Industry leaders are now focusing on creating new business practices to deal with such crises.


The North America allergy immunotherapies market, based on Treatment, is segmented into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).In 2019, the SCIT segment held a larger share of the market.

However, the SLIT segment is expected to grow at a higher CAGR during the forecast period.The North America allergy immunotherapies market, based on allergy type, is segmented into allergic rhinitis, asthma, food allergy, venom allergy, and others.

The allergic rhinitis segment held the greatest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during forecast period.

The North America allergy immunotherapies market, based on distribution channel, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. In 2019, the hospital pharmacy settings segment held the largest share of the market, and market for the same segment is expected to grow at the fastest CAGR during the forecast period.

A few of the major primary and secondary sources associated with this report on the North America allergy immunotherapies market are the American Academy of Allergy, Asthma & Immunology, Celsion Corporation, the US Food and Drug Administration (FDA), and World Allergy Organization (WAO).

Tags : #northamerica #immunotherapies #worldallergyorganization #covid19 #foodanddrugadministration

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024